A detailed history of Sit Investment Associates Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Sit Investment Associates Inc holds 97,048 shares of NVO stock, worth $10.2 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
97,048
Previous 102,312 5.15%
Holding current value
$10.2 Million
Previous $14.6 Million 20.87%
% of portfolio
0.26%
Previous 0.34%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$119.07 - $145.42 $626,784 - $765,490
-5,264 Reduced 5.15%
97,048 $11.6 Million
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $998,245 - $1.2 Million
8,135 Added 8.64%
102,312 $14.6 Million
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $4.19 Million - $5.58 Million
41,082 Added 77.37%
94,177 $12.1 Million
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $4.66 Million - $5.6 Million
53,095 New
53,095 $5.49 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Sit Investment Associates Inc Portfolio

Follow Sit Investment Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sit Investment Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sit Investment Associates Inc with notifications on news.